AstraZeneca Sets Two NMEs Per Year As Metric Of R&D Success
Executive Summary
AstraZeneca is setting a goal of launching two new molecular entities each year, Exec VP-Global Drug Development Martin Nicklasson, PhD, said Feb. 10 at a drug development summit sponsored by R&D Directions in Phoenix